Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

CD2_BENIGN_LIPO_SKIN_NOS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D17.3& Cause of death: ICD-10 — D17.3& 2 out of 7 registries used, show all original rules.	267
4. Check minimum number of events None	267
5. Include endpoints None	267
6. Filter based on genotype QC (FinnGen only)	256

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D17
Name in latin: Neoplasma benignum lipomatosum cutis sive textus subcutanei locis aliis sive non specificatis

NAME	CD2_BENIGN_LIPO_SKIN_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D173
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D173
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1781	992	781
Only index persons	1694	957	737
Unadjusted period prevalence (%)
Whole population	0.03	0.03	0.02
Only index persons	0.03	0.04	0.03
Median age at first event (years)
Whole population	52.02	53.10	50.59
Only index persons	51.49	52.86	49.72

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	256	159	97
Unadjusted period prevalence (%)	0.05	0.06	0.04
Median age at first event (years)	53.00	50.98	56.30

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
267: Matched controls
2670

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D17.3

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

4503599627370496.0

307.7

266

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

11.2

62.9

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

9.9

33.2

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

13.4

30.4

D17.9

ICD-10 Finland

Benign lipomatous neoplasm, unspecified

32.8

18.7

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

7.4

16.4

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

21.5

14.0

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

9.6

11.5

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

10.7

11.2

ZXE00

NOMESCO Finland

One hour or less

2.3

10.3

128

758

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

9.2

122

734

Z2221

NOMESCO Finland

Medical doctor

2.2

8.0

509

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.3

7.7

D17.0

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

9.8

7.4

Z3226

NOMESCO Finland

Physiotherapist

2.3

7.3

319

R4110

NOMESCO Finland

Physiotherapy

2.1

7.3

524

Z71.8

ICD-10 Finland

Other specified counselling

2.1

7.2

574

XLA10, ,

NOMESCO Finland

4.3

7.2

L72.1

ICD-10 Finland

Trichilemmal cyst

3.4

7.2

ZXA05

NOMESCO Finland

Left side

2.1

6.8

457

TQW99

NOMESCO Finland

Other minor procedure on skin

3.6

6.7

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

23.2

6.7

D17.7

ICD-10 Finland

Benign lipomatous neoplasm of other sites

71.5

6.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

6.1

529

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

132

924

1.85

5.69

2.3

2.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

257

2289

4.28

5.65

15.2

15.6

3.93

3.97

mmol/l

1.46

250

2227

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

240

2068

2.59

5.47

4.9

4.7

1.81

2.47

mu/l

0.59

226

1895

(3019550) Sodium [Moles/volume] in Serum or Plasma

256

2283

3.95

5.43

14.9

15.5

139.70

139.69

mmol/l

0.02

249

2222

(3002256) Pathology report gross observation

290

2.13

5.40

1.5

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

242

2115

2.54

4.95

14.1

12.8

80.99

80.86

ml/min/173m2

0.03

210

1744

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

249

2227

2.75

4.44

14.2

13.5

24.48

22.18

mg/l

0.44

191

1729

(3013139) Helicobacter pylori Ag [Presence] in Stool

149

2.30

4.23

1.1

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

138

1050

1.65

3.94

6.0

5.2

56.47

57.49

0.42

127

984

(3002030) Lymphocytes/100 leukocytes in Blood

139

1063

1.64

3.87

6.1

5.4

27.94

27.39

0.24

127

996

(3044889) 12 lead EKG panel

193

1610

1.72

3.79

3.3

3.8

—

(40768797) Stomach Pathology biopsy report

321

1.86

3.72

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

116

859

1.62

3.60

2.2

1.9

97.78

95.45

pmol/l

0.19

428

(3006504) Eosinophils/100 leukocytes in Blood

134

1029

1.61

3.57

6.1

5.4

3.11

2.79

0.73

123

957

(3022096) Basophils/100 leukocytes in Blood

130

993

1.60

3.53

6.2

5.4

0.68

0.66

0.17

119

920

(3051651) Icteric interference index of Serum or Plasma

6.31

3.52

3.9

3.1

—

(3048689) Calprotectin [Mass/mass] in Stool

257

1.90

3.50

2.7

2.3

58.51

129.20

ug/g

2.33

207

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

257

2378

3.16

3.47

11.0

10.3

24.93

25.80

u/l

0.34

247

2303

(3051611) Lipemic interference index of Serum or Plasma

5.13

3.40

3.7

2.8

—

(3019198) Lymphocytes [#/volume] in Blood

144

1135

1.58

3.37

6.1

5.4

1.87

2.01

e9/l

0.48

129

1006

(3013115) Eosinophils [#/volume] in Blood

145

1145

1.58

3.37

6.3

5.7

0.19

e9/l

0.25

130

1003

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.54

3.36

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.54

3.36

1.2

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

124

945

1.58

3.35

4.2

4.5

36.61

35.80

g/l

0.83

116

889

(3037467) Urinalysis macro (dipstick) panel - Urine

182

1520

1.62

3.30

4.2

4.0

—

(1002224) Polysomnography panel

104

2.33

3.26

1.1

—

(3018095) Leukocytes [#/volume] in Urine

106

783

1.59

3.25

3.5

89.56

59.34

e6/l

0.39

554

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

233

2091

1.90

3.10

5.5

5.7

39.07

39.90

mmol/mol

0.87

221

1954

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

244

2226

2.12

3.06

4.1

4.5

4.75

4.72

mmol/l

0.17

230

2068

(3019069) Monocytes/100 leukocytes in Blood

132

1037

1.54

3.03

6.3

5.6

8.53

0.01

121

970

(3013650) Neutrophils [#/volume] in Blood by Automated count

158

1297

1.53

2.92

9.6

9.3

3.91

4.11

e9/l

0.72

136

1118

(40758558) Short blood count panel - Blood

576

1.58

2.86

9.3

6.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.40

2.81

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

246

2264

2.10

2.79

5.0

2.82

2.79

mmol/l

0.24

232

2092

(3006315) Basophils [#/volume] in Blood

138

1108

1.51

2.78

6.1

5.4

0.04

e9/l

0.70

121

955

(42529406) Shigella sp [Presence] in Stool by Culture

2.37

2.74

1.2

—

(3001604) Monocytes [#/volume] in Blood

137

1107

1.49

2.63

6.2

5.4

0.57

0.58

e9/l

0.10

121

953

(3031040) Bacteria [#/volume] in Urine by Automated count

170

1438

1.50

2.58

4.2

4.1

—

26.80

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

113

884

1.48

2.52

2.5

2.3

78.80

77.30

nmol/l

0.21

102

790

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

472

1.56

2.43

1.4

1.7

1.37

1.12

mg/l

0.36

376

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.29

2.43

1.3

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

197

1733

1.52

2.35

3.9

14.64

14.79

pmol/l

0.33

187

1572

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

198

1748

1.51

2.29

7.9

7.3

78.00

78.08

u/l

0.01

183

1636

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

174

1505

1.45

2.17

2.8

3.0

43.10

49.67

u/l

0.46

164

1413

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

423

1.54

2.16

3.6

2.9

2.48

2.45

mmol/l

1.00

375

(40760892) CBC W Ordered Manual Differential panel - Blood

127

1040

1.42

2.13

5.8

5.9

—

(3021589) Normoblasts [#/volume] in Blood

123

1002

1.42

2.12

8.1

9.1

0.00

e9/l

0.58

103

826

(3044640) Blood type and Crossmatch panel - Blood

668

1.45

2.06

2.5

2.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

156

1.81

2.05

1.5

3.2

119.00

174.21

ng/l

0.74

139

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.56

2.04

1.3

1.2

—

(40761535) Cells panel - Urine sediment

187

0.41

2.02

1.5

3.3

—

(4146454) Self-monitoring of blood glucose

3.59

1.85

1.7

3.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

3.59

1.85

1.3

1.1

—

(40761511) CBC panel - Blood by Automated count

248

2343

1.82

1.76

11.0

12.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

164

1.72

1.76

3.3

3.6

81.27

78.69

ng/l

0.06

149

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

235

2190

1.61

1.76

4.6

5.94

5.95

mmol/l

0.01

218

2008

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

237

2214

1.63

1.74

4.2

4.4

1.47

1.49

mmol/l

0.24

223

2042

(3030467) Casts [#/volume] in Urine by Automated count

634

1.40

1.69

3.1

2.9

0.26

0.40

e6/l

0.56

467

(3004716) Salmonella sp identified in Stool by Organism specific culture

128

1.78

1.66

1.4

1.3

—

(3044941) Cell count panel - Synovial fluid

2.85

1.66

1.0

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

274

1.54

1.64

3.6

2.8

9.09

8.06

umol/l

0.11

244

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.62

1.62

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

405

1.45

1.60

1.6

1.7

888.19

1217.25

nmol/l

2.18

302

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

128

1086

1.34

1.59

5.9

6.5

1.21

1.22

mmol/l

0.05

112

921

(3052851) Hemolysis interference index of Serum or Plasma

2.08

1.57

3.4

3.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

381

1.45

1.55

3.3

3.0

0.62

0.73

ug/l

0.78

252

(36304419) Bacteria [Presence] in Urine

616

1.38

1.53

3.1

2.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.38

1.53

1.8

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.38

1.53

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

517

1.40

1.51

4.2

22.07

21.38

0.13

241

(3013826) Glucose [Moles/volume] in Serum or Plasma

145

1260

1.33

1.51

4.1

4.5

6.71

6.66

mmol/l

0.08

130

1173

(3019150) Specific gravity of Urine by Refractometry

494

0.66

1.45

2.4

3.7

1.02

kg/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.29

1.41

1.6

1.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

167

1.62

1.41

2.2

2.4

—

11.12

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

151

1.65

1.40

1.3

—

44.21

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

505

1.38

1.40

2.1

2.0

2.55

3.06

mg/l

1.03

430

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

371

1.43

1.40

3.0

2.5

0.69

1.05

e6/l

0.77

198

(3025130) Human papilloma virus identified in Specimen

2.45

1.40

1.1

1.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

796

1.32

1.35

3.0

—

(3002582) Erythrocytes [#/volume] in Urine

684

1.33

1.34

3.2

3.0

36.49

133.88

e6/l

0.50

517

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

339

1.43

1.34

3.2

2.8

2.87

2.53

e6/l

0.09

166

(3015377) Calcium [Moles/volume] in Serum or Plasma

779

1.32

1.33

4.2

3.3

2.39

2.35

mmol/l

2.09

694

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

494

1.36

1.28

2.1

—

(3021788) Differential panel - Synovial fluid

2.43

1.25

1.0

1.5

—

(3022145) Colonoscopy Study observation

258

1.46

1.22

1.4

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

116

999

1.28

1.21

2.2

2.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

282

0.61

1.20

6.1

7.2

—

(3029937) Albumin [Presence] in Urine by Test strip

619

0.73

1.20

3.0

3.7

0.00

estimate

-0.00

214

(4200892) Spirometry reversibility

166

1.56

1.20

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

373

1.38

1.20

1.7

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

1.16

0.0

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

420

1.36

1.16

2.9

3.7

1139.70

177.39

ng/l

0.41

321

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

651

1.30

1.15

5.3

4.9

1.61

2.50

ug/l

1.08

584

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

227

2144

1.39

1.13

3.7

4.0

1.35

1.29

mmol/l

0.63

211

1966

(4035726) Immunohistochemistry procedure

211

1.48

1.12

1.3

1.4

—

(3018418) pH of Serum or Plasma

700

1.29

1.12

4.6

3.7

7.39

7.40

0.18

127

(40768443) Skin Pathology biopsy report

1.73

1.10

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

145

1.56

1.10

1.8

1.4

—

(3005570) Glucose [Moles/volume] in Urine

2.41

1.09

1.6

2.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

115

1000

1.26

1.08

13.3

11.5

1.28

1.26

inr

0.06

306

(3000494) Fungus identified in Specimen by Culture

274

1.41

1.06

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

883

0.78

1.06

3.3

3.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.95

1.03

1.2

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.20

0.98

1.0

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

505

1.30

0.98

2.3

3.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1.88

0.98

2.3

0.30

0.37

u/ml

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.98

0.0

1.5

—

(3026782) Osmolality of Urine

441

1.31

0.97

2.6

2.9

575.00

543.64

mosm/kgh2o

0.50

376

(3003888) Timothy IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

4.88

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.65

0.96

1.7

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.85

0.93

1.4

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

114

1006

1.23

0.91

5.4

5.6

1.21

1.22

mmol/l

0.10

102

908

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

130

0.53

0.90

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

110

968

1.23

0.90

2.8

2.6

95.59

124.53

ug/l

1.94

101

888

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

240

1.38

0.87

1.3

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

340

1.32

0.84

1.2

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

676

1.24

0.83

2.8

3.0

7.88

7.63

mmol/l

0.14

570

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

140

1.46

0.79

2.0

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.79

0.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.79

0.0

3.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

1.15

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

237

1.35

0.77

1.3

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.78

0.77

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1.67

0.76

1.6

1.4

280.00

318.35

ug/g

—

(3000492) Spirometry study

202

1.37

0.76

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.63

0.76

1.9

1.7

—

(40761536) Microorganisms panel - Urine sediment

195

0.65

0.75

2.9

3.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

108

1.51

0.75

3.3

9.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

203

1.37

0.74

2.1

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.63

0.73

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

231

1.34

0.71

1.5

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1.73

0.70

1.7

1.5

251.14

236.11

pmol/l

—

(3003396) Base excess in Arterial blood by calculation

232

1.33

0.70

3.5

7.8

0.20

1.27

mmol/l

1.27

187

(3023520) Reticulocytes [#/volume] in Blood

188

1.36

0.69

2.4

2.8

77.99

71.12

e9/l

0.67

149

(3023183) Ammonium ion [Moles/volume] in Plasma

1.68

0.69

1.3

3.6

25.57

38.11

umol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.87

0.69

1.4

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.80

0.66

6.4

3.3

59.60

74.17

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.80

0.66

1.4

1.2

—

(1761868) Lipid panel - Serum or Plasma

842

0.83

0.65

2.7

2.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

253

1.30

0.65

2.7

2.8

1.95

1.77

0.45

226

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

151

1404

1.17

0.62

3.1

3.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

192

1.33

0.62

1.6

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.68

0.61

1.4

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

122

1.42

0.61

1.2

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

468

1.22

0.61

2.3

2.4

6.70

6.47

e6/l

0.03

419

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

0.60

0.0

1.2

—

94.40

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(3008295) Osmolality of Serum or Plasma

0.00

0.59

0.0

1.2

—

272.80

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

0.00

0.58

0.0

1.8

—

532.61

—

(4034850) Laboratory test

0.55

0.57

9.0

10.4

—

(3020891) Body temperature

0.55

0.57

7.2

4.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

179

1694

1.17

0.57

3.6

4.0

10.21

11.79

mm/h

0.94

164

1554

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.64

0.56

1.2

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.64

0.56

1.0

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.52

0.55

1.6

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

1.55

0.53

1.0

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

583

1.18

0.50

2.6

351.42

3713.62

umol/l

1.43

502

(3007930) Methemoglobin/Hemoglobin.total in Blood

1.45

0.50

2.5

4.9

0.93

0.89

0.14

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.47

0.49

1.1

2.0

—

(3042936) Bacteria identified in Isolate by Culture

307

0.80

0.47

1.8

—

(3015736) pH of Urine

888

1.15

0.46

2.7

3.2

6.00

5.94

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

121

1.34

0.45

1.1

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

119

1107

1.14

0.44

3.0

3.5

0.00

estimate

0.50

234

(3020682) Albumin/Creatinine [Ratio] in Urine

676

1.15

0.44

3.9

3.7

22.60

7.43

mg/mmol

0.44

427

(21494755) Public health laboratory ask at order entry panel

218

0.76

0.44

1.4

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

337

0.81

0.44

1.7

1.8

—

(3000991) Gas panel - Venous blood

167

1.28

0.43

3.8

8.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.62

0.43

1.6

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

241

1.23

0.42

1.7

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

269

1.22

0.42

4.6

6.8

105.53

104.12

mmol/l

0.90

269

(3021879) Hepatitis B virus core Ab [Presence] in Serum

141

1.30

0.41

1.2

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

11.0

—

1122.62

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

75.94

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

13.1

—

2101.44

—

(3024354) Oxygen [Partial pressure] in Venous blood

160

0.74

0.41

2.9

2.6

4.04

4.40

kpa

0.28

155

(3016879) Cocaine [Presence] in Urine

1.34

0.40

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

1.48

0.40

1.4

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

552.00

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.0

—

35.67

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

240.60

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.40

0.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.40

0.0

3.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.32

0.40

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.2

—

(3023368) Bacteria identified in Blood by Culture

577

1.14

0.38

3.2

4.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

143

1.28

0.38

1.2

99.28

331.62

u/ml

0.73

127

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.40

0.37

1.1

1.3

—

(3011288) Drugs identified in Urine by Screen method

1.36

0.37

1.0

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.36

0.34

1.3

—

3.07

—

(3041096) Erythrocytes [Presence] in Urine by Automated

629

0.88

0.34

3.6

3.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

515

1.14

0.33

1.6

1.5

17.24

21.37

nmol/l

2.04

428

(3039000) Anion gap in Blood

1.31

0.33

3.3

7.0

11.17

10.93

mmol/l

—

(3018572) Chloride [Moles/volume] in Blood

1.31

0.33

3.3

7.0

105.33

104.98

mmol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

174

1.22

0.32

1.4

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

382

1.15

0.32

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

344

1.16

0.32

2.1

2.2

15.60

13.70

umol/l

0.86

319

(3001019) Free T4 and TSH panel - Serum or Plasma

131

0.75

0.31

1.4

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

100

0.69

0.31

2.1

2.4

0.54

0.66

—

100

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

635

1.12

0.30

2.6

3.1

1401.75

1185.47

ng/l

0.15

539

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.32

0.30

2.6

4.9

1.59

1.61

0.03

(3000764) Benzodiazepines [Presence] in Urine

1.30

0.28

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1.26

0.27

1.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

1.26

0.27

1.1

1.2

—

(3027008) Opiates [Presence] in Urine

1.26

0.27

1.1

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

117

1113

1.09

0.27

4.5

4.6

0.00

estimate

-0.00

220

(4094501) Cardiovascular stress test using bicycle ergometer

1.20

0.26

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.20

0.26

3.4

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.31

0.26

1.6

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

294

1.14

0.24

2.1

2.3

27.02

23.04

0.65

255

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1.25

0.23

1.4

2.3

1.72

1.56

g/l

0.36

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.29

0.23

1.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.29

0.23

2.0

—

(3045414) Leukocytes [Presence] in Urine

0.76

0.23

1.9

1.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.22

0.22

1.0

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

103

0.77

0.21

2.0

2.3

1.23

1.19

—

103

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.21

0.0

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.21

0.0

15.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.12

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.21

0.0

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.4

—

62.33

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(44813793) Dust mix specific IgE antibody measurement

0.00

0.21

0.0

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

1.6

—

106.00

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

1.79

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

1.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.3

—

1.24

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.25

0.21

6.0

1.8

—

(3012516) Albumin [Mass/volume] in Urine

638

1.09

0.21

3.2

3.1

193.88

246.25

mg/l

0.10

421

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3035880) pH of Pleural fluid

0.00

0.21

0.0

1.1

—

(3012565) Volume of 24 hour Urine

0.00

0.21

0.0

2.5

—

2103.46

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3017704) Immunofixation for Urine

0.00

0.21

0.0

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.26

0.20

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate

0.00

0.20

0.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

0.00

0.20

0.0

1.2

—

422.21

—

(3009261) Glucose [Presence] in Urine by Test strip

117

1124

1.07

0.20

3.0

3.5

0.00

estimate

-0.00

208

(3008152) Bicarbonate [Moles/volume] in Arterial blood

133

0.82

0.20

6.5

7.1

24.48

24.47

mmol/l

0.01

127

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1.20

0.20

1.0

1.1

3.67

3.03

e6/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1.20

0.20

1.0

1.2

0.50

255.58

e6/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

258

0.88

0.18

5.2

4.5

31.12

32.14

0.25

169

(3019832) Treponema pallidum Ab [Presence] in Serum

147

1.17

0.18

1.4

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

464

0.91

0.18

1.3

2.30

2.39

g/l

0.19

270

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

195

0.86

0.18

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.13

0.17

1.3

1.1

—

(3013512) EKG study

646

0.93

0.17

3.6

3.8

—

(3047181) Lactate [Moles/volume] in Blood

1.11

0.17

3.4

6.6

1.07

1.14

mmol/l

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.73

0.17

1.2

1.3

—

2.95

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.71

0.17

1.2

—

1.88

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.13

0.16

1.0

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

835

1.06

0.15

2.8

3.7

16.69

27.44

ng/l

3.14

588

(3004588) Protein electrophoresis panel - Serum or Plasma

150

0.86

0.15

5.0

2.4

—

(3022313) Gas panel - Capillary blood

0.79

0.14

2.4

3.8

—

(3019060) Gas panel - Arterial blood

139

0.86

0.14

4.1

4.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

457

0.93

0.13

1.6

1.7

402.38

460.59

pmol/l

1.16

376

(3026008) Bacteria identified in Urine by Culture

660

1.06

0.13

3.5

2.8

—

(3022621) pH of Urine by Test strip

137

0.87

0.12

3.6

2.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

240

0.91

0.12

1.4

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.14

0.10

1.0

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

1.09

0.09

3.6

3.0

8.82

7.51

mmol/l

—

(3008037) Lactate [Moles/volume] in Venous blood

1.07

0.09

3.6

3.1

1.90

1.41

mmol/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.11

0.09

1.3

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

144

0.90

0.08

1.0

1.6

1.62

1.51

g/l

0.10

131

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.79

0.08

1.0

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

117

1.12

0.08

2.8

2.5

—

(3019225) pH of Specimen

196

1.08

0.07

4.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.84

0.07

1.6

1.7

—

(3025941) Bacteria identified in Stool by Culture

128

1.10

0.07

1.4

1.2

—

(3000330) Specific gravity of Urine by Test strip

101

0.89

0.06

6.7

3.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

384

0.96

0.05

1.2

1.3

1.48

7.51

u/ml

2.46

145

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

675

1.03

0.05

2.4

2.0

235.05

191.09

u/l

0.19

636

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

412

0.97

0.04

1.3

10.71

30.53

iu/ml

—

139

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

281

0.96

0.04

1.5

1.6

—

(3002032) Base excess in Venous blood by calculation

191

1.05

0.03

3.3

2.10

2.09

mmol/l

0.00

153

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

118

0.93

0.03

2.1

3.7

1.97

1.94

mmol/l

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

720

1.02

0.02

1.8

2.4

53.15

64.81

u/l

0.94

671

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

182

1.05

0.02

1.3

2.4

2.36

7.64

ug/l

2.77

165

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

216

0.97

0.00

2.6

3.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

129

1.01

0.00

5.0

3.1

4.43

4.52

pmol/l

0.13

112

(3021447) Carbon dioxide [Partial pressure] in Venous blood

193

0.98

0.00

3.4

3.3

5.95

5.70

kpa

1.07

188

(3002173) Hemoglobin [Mass/volume] in Arterial blood

196

1.02

0.00

4.3

8.6

125.50

120.11

g/l

0.78

191

(3003694) ABO and Rh group [Type] in Blood

584

0.99

0.00

1.3

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

524

0.99

0.00

1.3

0.61

1.00

u/ml

1.13

147

(3003327) Ova and parasites identified in Stool by Light microscopy

0.88

0.00

2.7

1.6

—

(3049717) Cytology report of Urine Cyto stain

0.91

-0.00

1.7

2.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

0.00

-0.00

0.0

1.0

—

68.14

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

2.2

—

114.11

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

38.67

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.7

—

7.32

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

2.4

—

(3003129) Base excess in Capillary blood by calculation

0.00

-0.00

0.0

1.2

—

3.34

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

1.91

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.1

—

(3034426) Prothrombin time (PT)

0.00

-0.00

0.0

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.49

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.02

-0.00

8.7

4.2

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.00

-0.00

0.0

5.2

—

25.86

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.3

—

(3022689) Creatine [Moles/volume] in Urine

0.00

-0.00

0.0

1.8

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(36660697) Celiac disease serology panel - Serum

190

1.00

-0.00

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

-0.00

0.0

4.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

-0.00

0.0

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.94

-0.00

2.5

2.4

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.00

-0.00

0.0

3.4

—

74.71

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.0

—

18.12

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

5.5

—

44.13

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

9.60

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.6

—

(3008898) HLA-B27 [Presence]

1.01

-0.00

1.0

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

2.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LIPO_SKIN_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_SKIN_NOS	0.961 [0.78, 1.19]	0.715
Birth year	0.994 [0.99, 1.0]	0.193

During the follow-up period (1.1.1998 — 31.12.2019), 112 out of 879 females with CD2_BENIGN_LIPO_SKIN_NOS died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LIPO_SKIN_NOS	1.001 [0.81, 1.23]	0.993
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 103 out of 695 males with CD2_BENIGN_LIPO_SKIN_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIPO_SKIN_NOS.

N-year risk	Females	Males
1	0.086%	0.191%
5	0.541%	1.153%
10	1.358%	2.721%
15	2.642%	5.416%
20	4.742%	9.295%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIPO_SKIN_NOS – Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints